The efficacy and safety of hydroxychloroquine in pregnant patients with IgA nephropathy: A retrospective cohort study
- 29 October 2021
- journal article
- research article
- Published by Wiley in Nephrology
- Vol. 27 (2) , 155-161
Abstract
Aim: Hydroxychloroquine (HCQ) is used to control proteinuria in IgA Nephropathy (IgAN) However, its efficacy and safety in pregnant IgAN patients remains unknown. This study aimed to verify the safety of HCQ in pregnant IgAN patients and compare renal function and pregnancy outcomes with those of patients not treated with HCQ.Methods: We retrospectively reviewed medical records of all pregnant IgAN patients and singleton gestations at Peking University First Hospital from 2003–2021. Patients who did and did not receive HCQ treatment during pregnancy were compared.Results: We found no significant pre‐ or post‐pregnancy differences in proteinuria or renal function between the two groups. However, the HCQ (+) group had higher proteinuria at the time of kidney biopsy (2.04 [1.26, 2.56] g/d vs. 0.80 [0.44, 1.11] g/d, P < .001); the proteinuria level at HCQ therapy initiation was also higher than that at the beginning of pregnancy (1.87 [1.30, 2.59] g/d vs. 1.08 [0.75, 1.50] g/d, P = .001). Despite no difference in preterm birth, birth weight, preeclampsia or postpartum haemorrhage, the proportion of patients with a previous history of spontaneous abortion was higher in the HCQ (+) group than in the HCQ (−) group (48.0% vs. 20.6%, P = .010). The eGFR (regression coefficient, 0.981; 95%CI 0.964–0.998) was a predictive factor for obstetrical complications.Conclusion: HCQ is safe for IgAN treatment during pregnancy with effective reduction of proteinuria. HCQ might also be helpful in patients with a history of spontaneous abortion.Keywords
This publication has 26 references indexed in Scilit:
- Excessive TLR9 signaling contributes to the pathogenesis of spontaneous abortion through impairment of Treg cell survival by activation of Caspase 8/3International Immunopharmacology, 2015
- A Systematic Review and Meta-Analysis of Outcomes of Pregnancy in CKD and CKD Outcomes in PregnancyClinical Journal of the American Society of Nephrology, 2015
- Risk of Adverse Pregnancy Outcomes in Women with CKDJournal of the American Society of Nephrology, 2015
- Pregnancy in advanced chronic kidney disease and end-stage renal diseaseCurrent Opinion in Nephrology and Hypertension, 2015
- Changing Spectrum of Biopsy-Proven Primary Glomerular Diseases over the Past 15 Years: A Single-Center Study in China2013
- National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implicationsThe Lancet, 2012
- Algorithms to estimate the beginning of pregnancy in administrative databasesPharmacoepidemiology and Drug Safety, 2012
- Ocular Toxicity in Children Exposedin Uteroto Antimalarial Drugs: Review of the LiteratureThe Journal of Rheumatology, 2011
- Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and ImidazoquinolinesThe Journal of Immunology, 2011
- Outcome studies of low birth weight infants published in the last decade: A metaanalysisThe Journal of Pediatrics, 1989